Abstract:(1) Background: Toad venom (Bufonis Venenum, known as 'Chansu' in Chinese), the secretion of the ear-side gland and skin gland of Bufo gargarizans cantor or Duttaphrynus melanostictus Schneider, has been utilized to treat several diseases in China for thousands of years. However, due to the chemical variability of the components, systematic chemical composition and the key pharmacophores in toad venom have not yet fully understood. Besides, it contains a variety of effective compounds with different physiological activity and chemotypes, mainly including alkaloids, bufogenins, bufotoxins, and so on. The recent pharmacological researches have demonstrated that several bufogenins have remarkable pharmacological effects, such as anti-inflammatory, analgesic effects, and anti-tumor effects. Aim of the study: To identify the bioactive compounds and pharmacophores originating from toad venom based on analyzing spectrum-effect relationship by chemometrics and to explore the anti-cancer mechanism primarily. (2) Materials and methods: Fingerprint of the 21 batches of samples was established using HPLC (High Performance Liquid Chromatography). The anti-tumor activity of extracts were determined by in-vitro assays. Chemometric analysis was used to establish the spectrum-effect model and screen for active ingredients. Pharmacodynamic tests for the screened active compound monomers were conducted with in-vitro assays. Further anti-tumor mechanisms were investigated using western blot and flow cytometry. (3) Results: The established spectrum-effect model has satisfactory fitting effect and predicting accuracy. The inhibitory effect of major screened compounds on lung carcinoma cells A549 were validated in vitro, demonstrating that arenobufagin, telocinobufogenin, and cinobufotalin had significant anti-tumor effects. Through further investigation of the mechanism by western blotting and flow cytometry, we elucidated that arenobufagin induces apoptosis in A549 cells with the enhanced expression of cleaved PARP (poly (ADP-ribose) polymerase). These results may provide valuable information for further structural modification of bufadienolides to treat lung cancer and a method for discovery of anti-tumor active compounds. Conclusions: Our research offers a more scientific method for screening the principal ingredients dominating the pharmacodynamic function. These screened compounds (arenobufagin, etc.) were proven to induce apoptosis by overactivation of the PARP-pathway, which may be utilized to make BRCA (breast cancer susceptibility gene) mutant cancer cells more vulnerable to DNA damaging agents and kill them.

Research Advancement in Effect of Scorpion Venom and Abstracts on Immunity

Rearch Progress on the Relationship Between Mast Cells and Cancer

The Antitumor Effect of Snake Venom Toxins and Its Application in Medical Field

Scorpion venoms and associated toxins as anticancer agents: update on their application and mechanism of action

Antimicrobial Potential of Scorpion-Venom-Derived Peptides

Identification of Antitumor Constituents in Toad Venom by Spectrum-Effect Relationship Analysis and Investigation on Its Pharmacologic Mechanism

Biological foundation and research progress on radiotherapy combined with immuno-therapy

Basic Research and Clinical Application of Acupuncture on Cancer Immunology

Advance in Effects of Selenium on Immune Function

Research advance of myeloid-derived suppressor cells on bionomics and immunosuppressive action and related immunotherapy

Scorpion venom peptides: Molecular diversity, structural characteristics, and therapeutic use from channelopathies to viral infections and cancers

Emerging anticancer potential and mechanisms of snake venom toxins: A review

Inhibitory Effects of Scorpion Venom and Its Components on Four Kinds of Tumor Cell Lines

Experimental Study of the Prophylactic and Therapeutic Effects of Venin on Metastasis and Recurrence of Liver Cancer

Research advance on exosome-based cancer immunotherapy

The application and research progress of anti-angiogenesis therapy in tumor immunotherapy

The Role of Tumor-Derived Exosomes in the Abscopal Effect and Immunotherapy

Research progress on the mechanism of tumor immune escape

Research progress in the anti-cancer activity and related mechanisms of arenobufagin

Research progress in the relationship between intestinal flora and tumor immunotherapy

Advancement in researches of the effects of perioperative analgesia on immune function of cancer patients